Literature DB >> 22365477

The Posttraumatic Stress Disorder Checklist as a screening measure for posttraumatic stress disorder in rehabilitation after burn injuries.

Paula J Gardner1, Dafna Knittel-Keren, Manuel Gomez.   

Abstract

OBJECTIVES: To determine the profile of posttraumatic stress disorder (PTSD) among outpatients with burn injuries referred to psychology in a rehabilitation hospital, and the utility of the Posttraumatic Stress Disorder Checklist-Civilian Version (PCL-C) as a screening measure for PTSD.
DESIGN: Retrospective psychological chart review.
SETTING: Outpatient burn clinic of a rehabilitation hospital. PARTICIPANTS: Outpatients (N=132) with burns referred to psychology between December 1999 and January 2010.
INTERVENTIONS: Psychological evaluation and self-report questionnaires measuring PTSD and depression. MAIN OUTCOME MEASURES: The Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition to assess clinical diagnosis of disorders, PCL-C to measure PTSD, and the Beck Depression Inventory-II to measure depression.
RESULTS: Of 132 outpatients, 127 (96%) had work-related injuries, 116 (88%) were men, and 16 (12%) were women. Mean age ± SD at injury was 39.0±11.1 years. Mean time from injury to assessment was 15.7±42.7 months. Burn etiology included: electrical (46.2%), scald (28.0%), flame (16.7%), chemical (5.3%), and contact (3.8%). Most patients (75%) were diagnosed with PTSD, either clinical (39.4%) or subclinical (35.6%). PTSD (clinical or subclinical) was frequently diagnosed in the following etiology groups: scald (85.7%), flame (77.3%), and electrical (74.6%). There were significant relationships between PTSD and depression (P<.001), and between subclinical PTSD and adjustment disorder (P<.03). PCL-C mean scores ± SD in the clinical and subclinical PTSD groups were 59.7±8.9 and 43.5±15.6, respectively. A PCL-C total score of 50 or higher had a sensitivity of 90% and specificity of 79% for PTSD diagnosis.
CONCLUSIONS: There was a high prevalence of PTSD (clinical or subclinical) among outpatients with burns referred to psychology. Prospective screening of psychological symptoms, clinical assessment, and intervention is warranted, especially for patients with work-related burn injuries. Our results suggest that PCL-C is a useful screening measure for PTSD in patients with burns.
Copyright © 2012 American Congress of Rehabilitation Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22365477     DOI: 10.1016/j.apmr.2011.11.015

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  5 in total

1.  Predicting Depression and Posttraumatic Stress Symptoms Following Burn Injury: A Risk Scoring System.

Authors:  Olivia R Stockly; Audrey E Wolfe; Richard Goldstein; Kimberly Roaten; Shelley Wiechman; Nhi-Ha Trinh; Jeremy Goverman; Frederick J Stoddard; Ross Zafonte; Colleen M Ryan; Jeffrey C Schneider
Journal:  J Burn Care Res       Date:  2022-07-01       Impact factor: 1.819

2.  Improving outcomes for care partners of persons with traumatic brain injury: Protocol for a randomized control trial of a just-in-time-adaptive self-management intervention.

Authors:  Noelle E Carlozzi; Angelle M Sander; Sung Won Choi; Zhenke Wu; Jennifer A Miner; Angela K Lyden; Christopher Graves; Srijan Sen
Journal:  PLoS One       Date:  2022-06-09       Impact factor: 3.752

3.  Work-related burn injuries in Ontario, Canada: A follow-up 10-year retrospective study.

Authors:  Elsa Clouatre; Manuel Gomez; Joanne M Banfield; Marc G Jeschke
Journal:  Burns       Date:  2013-01-22       Impact factor: 2.744

Review 4.  Effect of hyperbaric oxygenation therapy on post-concussion syndrome.

Authors:  Yan Dong; Xiaohua Hu; Tao Wu; Tong Wang
Journal:  Exp Ther Med       Date:  2018-07-18       Impact factor: 2.447

5.  Qualitative research investigating the mental health care service gap in Chinese burn injury patients.

Authors:  Zhengjia Ren; PeiChao Zhang; HongTao Wang; Hongyan Wang
Journal:  BMC Health Serv Res       Date:  2018-11-28       Impact factor: 2.655

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.